Ser231

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser231 - JARID2 (human)

Site Information
VFNGSSRsTREKEPV SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 50840406

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	breast cancer ( 1 )
Relevant cell line - cell type - tissue:	BT-20 (breast cell) ( 1 ) , BT-549 (breast cell) ( 1 ) , MDA-MB-231 (breast cell) ( 1 ) , MDA-MB-468 (breast cell) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.